查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1696290

全球智慧型手機醫療設備市場 - 2025 年至 2033 年

Global Smartphone Enabled Medical Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球智慧型手機醫療設備市場規模達到 227.6 億美元，預計到 2033 年將達到 891.5 億美元，2025-2033 年預測期內的複合年成長率為 14.6%。

支援智慧型手機的醫療設備，例如穿戴式心電圖監測儀、血糖儀、脈搏血氧儀和數位聽診器，是與手機整合以監測、診斷和管理醫療狀況的即時醫療保健工具。這些設備使用智慧型手機應用程式、無線連接和感測器來收集和傳輸患者資料，提高了可近性、早期疾病檢測和個人化醫療，使其成為現代數位健康解決方案的重要組成部分。

市場動態：

促進因素與約束因素

遠距醫療和遠距病人監控的普及率不斷提高

由於遠距醫療和遠距病人監控（尤其是在慢性病領域）的興起，全球智慧型手機醫療設備市場正在獲得發展動力。這些設備提供即時資料追蹤，改善患者的治療效果。行動醫療解決方案的便利性、無線連接的進步以及人工智慧驅動的診斷正在推動市場成長，同時智慧型手機普及率的提高和患者對非侵入性監測的偏好也在推動需求。

例如，2024年12月，領先的數位醫學和生物標記公司ElectronRx在2025年消費性電子展上推出了一款旨在滿足醫療器材標準的心肺評估應用程式purpleDx。該應用程式可讓慢性呼吸系統疾病患者在家中監測肺功能，為臨床醫生提供即時資料，以客製化治療方案並改善患者治療效果。

資料隱私和安全問題

由於資料隱私和安全問題，全球智慧型手機醫療設備市場面臨挑戰。這些設備收集和傳輸敏感的患者健康資料，使其容易受到網路威脅和未經授權的存取。缺乏標準化的資料保護法規使合規性變得複雜，而對第三方存取、駭客風險和醫療資訊潛在濫用的擔憂阻礙了其廣泛採用。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

第3章：市場亮點與策略要點

  • 主要趨勢和未來預測

第 4 章：依產品類型分類

  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 5 章：動態

  • 影響因素
    • 驅動程式
      • 遠距醫療和遠距病人監控的普及率不斷提高
      • 智慧型手機和行動健康應用的普及率不斷提高
    • 限制
      • 資料隱私和安全問題
      • 監理挑戰與核准複雜性
    • 機會
      • 用於即時健康追蹤的先進生物感測器的開發
    • 影響分析

第6章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 7 章：按產品類型

  • 診斷設備
  • 監控設備
  • 治療設備
  • 健身和健康設備
  • 其他

第 8 章：按應用

  • 病人監護
  • 慢性病管理
  • 健身追蹤
  • 遠端診斷

第 9 章：按最終用戶

  • 醫院和診所
  • 家庭護理設置
  • 健身中心

第 10 章：區域市場分析與成長機會

第 11 章：簡介

  • 北美洲
    • 各區域關鍵動態
      • 美國
      • 加拿大
  • 歐洲
    • 各區域關鍵動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 拉丁美洲
    • 各區域關鍵動態
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 各區域關鍵動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 各區域關鍵動態

第 12 章：競爭格局與市場定位

第 13 章：競爭概況與主要市場參與者

  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 14 章：公司簡介

  • Apple Inc
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量

第 15 章：財務概況

  • 公司收入
    • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • 三星電子
  • DexCom 公司
  • 馬西莫公司
  • 索諾瓦控股公司
  • 歐拉健康有限公司
  • 博雅有限公司
  • 美敦力
  • 雅培實驗室
  • AliveCor, Inc 清單並非詳盡無遺

第 16 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 17 章：附錄

簡介目錄
Product Code: MD9413

The global smartphone enabled medical devices market reached US$ 22.76 billion in 2024 and is expected to reach US$ 89.15 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smartphone-enabled medical devices, such as wearable ECG monitors, glucose meters, pulse oximeters, and digital stethoscopes, are real-time healthcare tools that integrate with mobile phones to monitor, diagnose, and manage medical conditions. These devices use smartphone applications, wireless connectivity, and sensors to collect and transmit patient data, improving accessibility, early disease detection, and personalized healthcare, making them a crucial part of modern digital health solutions.

Market Dynamics: Drivers & Restraints

Growing Adoption of Telemedicine and Remote Patient Monitoring

The global smartphone-enabled medical devices market is gaining momentum due to the rise in telemedicine and remote patient monitoring, particularly in chronic diseases. These devices offer real-time data tracking, improving patient outcomes. The convenience of mobile health solutions, advancements in wireless connectivity, and AI-driven diagnostics are driving market growth while increasing smartphone penetration and patient preference for non-invasive monitoring are also driving demand.

For instance, in December 2024, ElectronRx, a leading digital medicine and biomarker company, launched purpleDx, a cardiopulmonary assessment app designed to meet medical device standards at CES 2025. The app allows chronic respiratory disease patients to monitor lung function at home, providing real-time data for clinicians to customize treatment plans and improve patient outcomes.

Data Privacy and Security Concerns

The global smartphone-enabled medical devices market faces challenges due to data privacy and security concerns. These devices collect and transmit sensitive patient health data, making them vulnerable to cyber threats and unauthorized access. The lack of standardized data protection regulations complicates compliance, and concerns about third-party access, hacking risks, and potential misuse of medical information hinder widespread adoption.

Segment Analysis

The global smartphone enabled medical devices market is segmented based on product type, application, end-user and region.

Product Type:

The diagnostic devices from product type segment is expected to dominate the smartphone enabled medical devices market with the highest market share

Diagnostic devices are medical instruments used to detect, monitor, and analyze diseases in patients. They range from imaging systems like MRI and CT scans to portable tools like glucose monitors and ECG devices. Modern diagnostic devices offer enhanced accuracy, portability, and real-time data integration, making them essential in clinical and home healthcare settings.

The diagnostic devices market is driven by the rise in chronic and infectious diseases, fueled by technological advancements like AI-driven diagnostics, point-of-care testing, and smartphone-enabled devices. The focus on personalized medicine and government initiatives to improve healthcare infrastructure also contribute to market growth. Telemedicine and home-based diagnostic solutions, driven by smartphone penetration and wearable health technologies, further fuel global adoption.

For instance, in August 2023, GE HealthCare received FDA clearance for its Portrait Mobile wireless and wearable monitoring solution, which offers real-time continuous monitoring and personalized patient vitals tracking. The platform keeps patients mobile during critical recovery periods, particularly after surgery or intensive care unit discharge.

Geographical Analysis

North America is expected to hold a significant position in the smartphone enabled medical devices market with the highest market share

North America dominates the diagnostic devices market due to its advanced healthcare infrastructure, innovative medical technologies, and key industry players. The rising prevalence of chronic diseases like diabetes, cardiovascular disorders, and cancer drives demand for accurate diagnostics. Government investments, favorable reimbursement policies, telemedicine expansion, home-based diagnostic solutions, and AI-powered devices are accelerating adoption across the region.

For instance, in March 2025, Smart Meter, a leader in remote patient monitoring (RPM) solutions, partnered with FibriCheck to launch their Atrial Fibrillation (Afib) detection app in the U.S. The app uses smartphones as diagnostic tools, enabling users to control their heart health. FibriCheck uses advanced algorithms and the built-in camera on smartphones to detect irregular heart rhythms, potentially signaling Afib, a leading cause of stroke and cardiovascular complications. Smart Meter's seamless integration allows healthcare professionals to access near real-time heart rhythm data, enabling faster intervention and improved patient outcomes.

Competitive Landscape

The major global players in the smartphone enabled medical devices market include Apple Inc, Samsung Electronics, DexCom, Inc, Masimo Corporation, Sonova Holding AG, Oura Health Ltd, Beurer GmbH, Medtronic, Abbott Laboratories, and AliveCor, Inc, among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smartphone enabled medical devices market report delivers a detailed analysis with 62 key tables, more than 55 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

3. Market Highlights and Strategic Takeaways

  • 3.1. Key Trends and Future Projections

4. Snippet by Product Type

  • 4.1. Snippet by Application
  • 4.2. Snippet by End-User
  • 4.3. Snippet by Region

5. Dynamics

  • 5.1. Impacting Factors
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Adoption of Telemedicine and Remote Patient Monitoring
      • 5.1.1.2. Increasing Penetration of Smartphones and Mobile Health Apps
    • 5.1.2. Restraints
      • 5.1.2.1. Data Privacy and Security Concerns
      • 5.1.2.2. Regulatory Challenges and Approval Complexities
    • 5.1.3. Opportunity
      • 5.1.3.1. Development of Advanced Biosensors for Real-time Health Tracking
    • 5.1.4. Impact Analysis

6. Strategic Insights and Industry Outlook

  • 6.1. Market Leaders and Pioneers
    • 6.1.1. Emerging Pioneers and Prominent Players
    • 6.1.2. Established leaders with largest selling Brand
    • 6.1.3. Market leaders with established Product
  • 6.2. CXO Perspectives
  • 6.3. Latest Developments and Breakthroughs
  • 6.4. Case Studies/Ongoing Research
  • 6.5. Regulatory and Reimbursement Landscape
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East & Africa
  • 6.6. Porter's Five Force Analysis
  • 6.7. Supply Chain Analysis
  • 6.8. Patent Analysis
  • 6.9. SWOT Analysis
  • 6.10. Unmet Needs and Gaps
  • 6.11. Recommended Strategies for Market Entry and Expansion
  • 6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 6.13. Pricing Analysis and Price Dynamics
  • 6.14. Key Opinion Leaders

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Diagnostic Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Monitoring Devices
  • 7.4. Therapeutic Devices
  • 7.5. Fitness and Wellness Devices
  • 7.6. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Patient Monitoring*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Chronic Disease Management
  • 8.4. Fitness Tracking
  • 8.5. Remote Diagnostics

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Home Care Settings
  • 9.4. Fitness Centers

10. Regional Market Analysis and Growth Opportunities

11. Introduction

  • 11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.1. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Spain
      • 11.3.6.5. Italy
      • 11.3.6.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Mexico
      • 11.4.6.2. Brazil
      • 11.4.6.3. Argentina
      • 11.4.6.4. Rest of Latin America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. South Korea
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape and Market Positioning

13. Competitive Overview and Key Market Players

  • 13.1. Market Share Analysis and Positioning Matrix
  • 13.2. Strategic Partnerships, Mergers & Acquisitions
  • 13.3. Key Developments in Product Portfolios and Innovations
  • 13.4. Company Benchmarking

14. Company Profiles

  • 14.1. Apple Inc*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio
      • 14.1.2.1. Product Description
      • 14.1.2.2. Product Key Performance Indicators (KPIs)
      • 14.1.2.3. Historic and Forecasted Product Sales
      • 14.1.2.4. Product Sales Volume

15. Financial Overview

  • 15.1. Company Revenue's
    • 15.1.1. Geographical Revenue Shares
      • 15.1.1.1. Revenue Forecasts
    • 15.1.2. Key Developments
      • 15.1.2.1. Mergers & Acquisitions
      • 15.1.2.2. Key Product Development Activities
      • 15.1.2.3. Regulatory Approvals, etc.
    • 15.1.3. SWOT Analysis
  • 15.2. Samsung Electronics
  • 15.3. DexCom, Inc
  • 15.4. Masimo Corporation
  • 15.5. Sonova Holding AG
  • 15.6. Oura Health Ltd
  • 15.7. Beurer GmbH
  • 15.8. Medtronic
  • 15.9. Abbott Laboratories
  • 15.10. AliveCor, Inc LIST NOT EXHAUSTIVE

16. Assumption and Research Methodology

  • 16.1. Data Collection Methods
  • 16.2. Data Triangulation
  • 16.3. Forecasting Techniques
  • 16.4. Data Verification and Validation

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us